Skip to content
ABVCAbvc Biopharma, Inc.

ABVC holders

Who holds Abvc Biopharma, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.
Managers
13
Shares held
1.3M
Value held
$1.4M
Opened
3
Closed
4

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Vanguard Capital Management LLC569.2K+52.0%$603.3K0%Nov 13, 2026
Geode Capital Management, LLC236.7K+3.8%$251K0%Nov 6, 2026
UBS Group AG139.2K+307.9%$147.5K0%Nov 10, 2026
Vanguard Fiduciary Trust Co97.4K±0%$103.2K0%Nov 13, 2026
State Street Corp91.3K+25.4%$96.8K0%Nov 12, 2026
BlackRock, Inc.56.4K±0%$59.8K0%Nov 13, 2026
Northern Trust Corp48.6K±0%$51.6K0%Nov 16, 2026
Panagora Asset Management Inc36.7K±0%$38.9K0.1%Nov 12, 2026
Citadel Advisors LLC29.4K−59.2%$31.2K0%Nov 16, 2026
Squarepoint Ops LLC11.4KNew$12.1K0%Nov 9, 2026
Barclays PLC2New$20%Nov 6, 2026
Caitong International Asset Management Co., Ltd1−83.3%$10%Oct 29, 2026
SBI Securities Co., Ltd.1New$10%Oct 22, 2026